Tuesday, 13 Nov 2018

Bangla Version

Dengue vaccine not deadly: Sanofi, Philippines

No icon Spot Light

Health Desk: Dec 4, 2017--- A world-first dengue vaccination programme in the Philippines that was suspended over safety concerns will not cause anyone who was immunised to die, drug manufacturer Sanofi and local authorities said on Monday.

The Philippines on Friday suspended the programme, after more than 733,000 people had been immunised, in response to a statement from Sanofi that its vaccine could cause "more cases of severe disease" for people who had not previously had the mosquito-borne ailment.

After news outlets and some politicians in the Philippines expressed concern about the welfare of those immunised, the French pharaceutical giant held a press conference in Manila to state the potential cases of "severe dengue" would not be fatal.

"What is this severe (dengue)? When people think of 'severe', this already includes dengue shock that could lead to death, but no," Sanofi Pasteur regional head for dengue Joselito Sta. Ana told reporters.